Laurent and Caroline share their insights into the ambitions of this edition and the commitment of the entire sector. This year, a unifying theme takes center stage: “Together, let’s showcase French innovation as a driver of competitiveness.”

JNBB demonstrates that by bringing together the key players of our ecosystem, collective intelligence becomes a powerful driver of progress and growth!

For many years, international cooperation has been built primarily through institutional, diplomatic, or scientific relationships.

Today, a new dynamic is emerging: that of true industry diplomacy. By bringing together the entire French bioproduction value chain, France BioLead aims to contribute to this momentum. Our role is not limited to structuring the national ecosystem; it also involves creating the right conditions for the development of high-value international collaborations benefiting our companies, research centers, technology platforms, and talents. In this perspective, Canada stands out as a key partner. Scientific excellence, industrial ambition, investments in biotechnology, and a shared commitment to strengthening health sovereignty: the areas of complementarity are numerous.

During the Franco-Canadian panel organized as part of the JNBB, Laurent LAFFERRÈRE, Anne Jouvenceau, Philippe Charreau, Ritu Banerjee, Wendy Zatylny, Mark Lievonen, and Trina Racine share their insights into the synergies between the French and Canadian ecosystems, as well as the levers that can accelerate the development of biopharmaceuticals.

Discover how the complementary expertise of Calipso Sensors, Capgemini, CEA-Leti, Sanofi, and Ypso-Facto enables better control of complex biological processes to accelerate production, improve robustness, and ensure cost sustainability — transforming a shared ambition into tangible results for the future of biopharmaceutical manufacturing. 

Innovation, knowledge sharing, industrial and scientific excellence: this video demonstrates that tomorrow’s major challenges can only be addressed through collective efforts.

Taking part in JNBB means:

✅ Showcasing your expertise and increasing your visibility within the ecosystem
✅ Engaging with decision-makers, industry leaders, biotech companies, academics, and sector partners
✅ Creating new opportunities for collaboration, innovation, and development
✅ Building strategic connections in France and internationally, with Canada as the guest of honor in 2026
✅ Joining a collective movement to strengthen the visibility, attractiveness, and sovereignty of the sector

A huge thank you to the members of France BioLead who mobilized across the regions, as well as to the committed partners who contributed to the success of this edition.

We would also like to thank all participants, visitors, students, professionals, and curious minds who came to discover, learn, and perhaps join this strategic sector for healthcare and France’s industrial future.

We invite you to (re)discover what happened across France for #JNBB2026.

And… see you next year! 👋